Baird Financial Group, Inc. Astrazeneca PLC Transaction History
Baird Financial Group, Inc.
- $47.6 Billion
- Q2 2024
A detailed history of Baird Financial Group, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Baird Financial Group, Inc. holds 247,666 shares of AZN stock, worth $18.6 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
247,666
Previous 240,951
2.79%
Holding current value
$18.6 Million
Previous $16.3 Million
18.32%
% of portfolio
0.04%
Previous 0.03%
Shares
29 transactions
Others Institutions Holding AZN
# of Institutions
1,343Shares Held
492MCall Options Held
4.99MPut Options Held
3.19M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$4.88 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42.6MShares$3.2 Billion2.44% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$3.05 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$2.76 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA17.6MShares$1.32 Billion0.44% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $233B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...